195 related articles for article (PubMed ID: 27354540)
21. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.
Kent P; Wilkinson N; Constante M; Fillebeen C; Gkouvatsos K; Wagner J; Buffler M; Becker C; Schümann K; Santos MM; Pantopoulos K
J Mol Med (Berl); 2015 May; 93(5):489-98. PubMed ID: 25609138
[TBL] [Abstract][Full Text] [Related]
22. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
23. Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin.
Herrmann T; Muckenthaler M; van der Hoeven F; Brennan K; Gehrke SG; Hubert N; Sergi C; Gröne HJ; Kaiser I; Gosch I; Volkmann M; Riedel HD; Hentze MW; Stewart AF; Stremmel W
J Mol Med (Berl); 2004 Jan; 82(1):39-48. PubMed ID: 14618243
[TBL] [Abstract][Full Text] [Related]
24. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
[TBL] [Abstract][Full Text] [Related]
25. Nuclear iron deposits in hepatocytes of iron-loaded HFE-knock-out mice: a morphometric and immunocytochemical analysis.
Magens B; Düllmann J; Schümann K; Wulfhekel U; Nielsen P
Acta Histochem; 2005; 107(1):57-65. PubMed ID: 15866286
[TBL] [Abstract][Full Text] [Related]
26. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
Bonkovsky HL; Jawaid Q; Tortorelli K; LeClair P; Cobb J; Lambrecht RW; Banner BF
J Hepatol; 1999 Sep; 31(3):421-9. PubMed ID: 10488699
[TBL] [Abstract][Full Text] [Related]
27. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
28. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
29. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
[TBL] [Abstract][Full Text] [Related]
30. Iron overload and diabetes risk: a shift from glucose to Fatty Acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis.
Huang J; Jones D; Luo B; Sanderson M; Soto J; Abel ED; Cooksey RC; McClain DA
Diabetes; 2011 Jan; 60(1):80-7. PubMed ID: 20876715
[TBL] [Abstract][Full Text] [Related]
31. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
[TBL] [Abstract][Full Text] [Related]
32. Iron overload before cecal ligation and puncture increases mortality.
Wizorek JJ; Turnbull IR; Buchman TG
Shock; 2003 Jul; 20(1):52-5. PubMed ID: 12813369
[TBL] [Abstract][Full Text] [Related]
33. Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor-α-mediated fatty acid oxidation.
Wu X; Zheng H; Yang R; Luan X; Zhang L; Jin Q; Jin Y; Xue J
Am J Physiol Endocrinol Metab; 2019 Sep; 317(3):E436-E445. PubMed ID: 31211621
[TBL] [Abstract][Full Text] [Related]
34. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity.
Régnier M; Polizzi A; Smati S; Lukowicz C; Fougerat A; Lippi Y; Fouché E; Lasserre F; Naylies C; Bétoulières C; Barquissau V; Mouisel E; Bertrand-Michel J; Batut A; Saati TA; Canlet C; Tremblay-Franco M; Ellero-Simatos S; Langin D; Postic C; Wahli W; Loiseau N; Guillou H; Montagner A
Sci Rep; 2020 Apr; 10(1):6489. PubMed ID: 32300166
[TBL] [Abstract][Full Text] [Related]
36. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.
Latour C; Besson-Fournier C; Meynard D; Silvestri L; Gourbeyre O; Aguilar-Martinez P; Schmidt PJ; Fleming MD; Roth MP; Coppin H
Hepatology; 2016 Jan; 63(1):126-37. PubMed ID: 26406355
[TBL] [Abstract][Full Text] [Related]
37. A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice.
Padda RS; Gkouvatsos K; Guido M; Mui J; Vali H; Pantopoulos K
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G251-61. PubMed ID: 25501544
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis.
Cooksey RC; Jouihan HA; Ajioka RS; Hazel MW; Jones DL; Kushner JP; McClain DA
Endocrinology; 2004 Nov; 145(11):5305-12. PubMed ID: 15308612
[TBL] [Abstract][Full Text] [Related]
39. Lipocalin-type prostaglandin D
Kumar S; Srivastava A; Palaia T; Hall C; Lee J; Stevenson M; Zhao CL; Ragolia L
Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106429. PubMed ID: 32145387
[TBL] [Abstract][Full Text] [Related]
40. Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation.
Bernsmeier C; Dill MT; Provenzano A; Makowska Z; Krol I; Muscogiuri G; Semela D; Tornillo L; Marra F; Heim MH; Duong FH
Lab Invest; 2016 Sep; 96(9):972-80. PubMed ID: 27428080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
